Hayag, Aelon Luke N.
HRN: 22-13-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFUROXIME 1.5GM (VIAL)
09/21/2023
09/28/2023
IVT
290mg
Q8
PCAP-C; R/O PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes